Cover Image

Dihydroartemisinin Inhibits Laser-Induced Choroidal Neovascularization in a Mouse Model of Neovascular AMD

Purpose: Choroidal neovascularization (CNV) is the main pathogenic process and a leading cause of severe vision loss in neovascular age-related macular degeneration (AMD). We investigated the antiangiogenic efficacy of dihydroartemisinin (DHA) in an experimental laser-induced CNV mouse model.Methods...

Full description

Saved in:

Bibliographic Details
Main Authors:	Xun Li (Author), Sheng Gao (Author), Yun Zhang (Author), Mei Xin (Author), Cheng Zuo (Author), Naihong Yan (Author), Qingjie Xia (Author), Meixia Zhang (Author)
Format:	Book
Published:	Frontiers Media S.A., 2022-02-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Efficacy and Safety of Anti-Vascular Endothelial Growth Factor Monotherapies for Neovascular Age-Related Macular Degeneration: A Mixed Treatment Comparison
by: Yun Zhang, et al.
Published: (2021)

Secukinumab Associated Choroidal Neovascularization
by: Edward B Miller, et al.
Published: (2022)

Cytokine and Chemokine Profile Changes in Patients with Neovascular Age-Related Macular Degeneration After Intravitreal Ranibizumab Injection for Choroidal Neovascularization
by: Sun T, et al.
Published: (2021)

Choroidal Neovascularization: Mechanisms of Endothelial Dysfunction
by: Natalie Jia Ying Yeo, et al.
Published: (2019)

Pyroptosis: A New Insight Into Eye Disease Therapy
by: Yun Zhang, et al.
Published: (2021)

Multivesicular liposomes for sustained release of bevacizumab in treating laser-induced choroidal neovascularization
by: Hongjie Mu, et al.
Published: (2018)

Intravenous route to choroidal neovascularization by macrophage-disguised nanocarriers for mTOR modulation
by: Weiyi Xia, et al.
Published: (2022)

Metabolomics study of treatment response to conbercept of patients with neovascular age-related macular degeneration and polypoidal choroidal vasculopathy
by: Yinchen Shen, et al.
Published: (2022)

Matrix Metalloproteinase 13 Is Associated with Age-Related Choroidal Neovascularization
by: Jorge González-Zamora, et al.
Published: (2023)

Sustained-Release Microspheres of Rivoceranib for the Treatment of Subfoveal Choroidal Neovascularization
by: E Seul Kim, et al.
Published: (2021)

Optical coherence tomography angiography as an indicator of the efficacy of treatment for choroidal neovascularization
by: F. A. Bakhritdinova, et al.
Published: (2022)

Anti-VEGF treatment for myopic choroid neovascularization: from molecular characterization to update on clinical application
by: Zhang Y, et al.
Published: (2015)

Inhibition of Pathological Retinal Neovascularization by a Small Peptide Derived from Human Tissue-Type Plasminogen Kringle 2
by: Qian Sun, et al.
Published: (2020)

Adeno-Associated Viral Vector-Mediated mTOR Inhibition by Short Hairpin RNA Suppresses Laser-Induced Choroidal Neovascularization
by: Tae Kwann Park, et al.
Published: (2017)

Suppression of Choroidal Neovascularization by AAV-Based Dual-Acting Antiangiogenic Gene Therapy
by: Anne Louise Askou, et al.
Published: (2019)

Inflammatory Mediators and Angiogenic Factors in Choroidal Neovascularization: Pathogenetic Interactions and Therapeutic Implications
by: Claudio Campa, et al.
Published: (2010)

Mingjing granule inhibits the subretinal fibrovascular membrane of two-stage laser-induced neovascular age-related macular degeneration in rats
by: Xiaoyu Li, et al.
Published: (2024)

Comparative Efficacy of Pharmacotherapy for Macular Edema Secondary to Retinal Vein Occlusion: A Network Meta-analysis
by: Sheng Gao, et al.
Published: (2021)

CRISPR-based VEGF suppression using paired guide RNAs for treatment of choroidal neovascularization
by: Sook Hyun Chung, et al.
Published: (2022)

Resolution of vitreomacular traction following intravitreal ranibizumab in cases of ocular toxoplasmosis with choroidal neovascularization
by: Petrou P, et al.
Published: (2013)

Ten-Year Outcomes of Intravitreal Bevacizumab for Myopic Choroidal Neovascularization: Analysis of Prognostic Factors
by: Fabiana Mallone, et al.
Published: (2021)

Preliminary in vitro and in vivo assessment of a new targeted inhibitor for choroidal neovascularization in age-related macular degeneration
by: Li W, et al.
Published: (2016)

CircRNA in ocular neovascular diseases: Fundamental mechanism and clinical potential
by: Wenxin Zhang, et al.
Published: (2023)

EFEMP1 Overexpression Contributes to Neovascularization in Age-Related Macular Degeneration
by: Lu Cheng, et al.
Published: (2021)

Conbercept for Treatment of Neovascular Age-Related Macular Degeneration and Visual Impairment due to Diabetic Macular Edema or Pathologic Myopia Choroidal Neovascularization: A Systematic Review and Meta-Analysis
by: Pengxiang Zhou, et al.
Published: (2021)

Cost-effectiveness analysis of brolucizumab versus aflibercept for the treatment of neovascular age-related macular degeneration (nAMD) in Italy
by: Nicola Ferrante, et al.
Published: (2022)

Extensive preclinical evaluation of combined mangiferin and glycyrrhizic acid for restricting synovial neovascularization in rheumatoid arthritis
by: Xia Mao, et al.
Published: (2023)

Lactoferrin Has a Therapeutic Effect via HIF Inhibition in a Murine Model of Choroidal Neovascularization
by: Mari Ibuki, et al.
Published: (2020)

Suppression of Choroidal Neovascularization and Fibrosis by a Novel RNAi Therapeutic Agent against (Pro)renin Receptor
by: Ye Liu, et al.
Published: (2019)

Arteriogenesis and Therapeutic Neovascularization
Published: (2020)

Comparing The Efficacy Of An Anti-Human VEGF-A Neutralizing Antibody Versus Bevacizumab On A Laser-Induced Choroidal Neovascularization (CNV) Rhesus Monkey Model
by: Olvera-Montaño O, et al.
Published: (2019)

A Fully Human Monoclonal Antibody Targeting cKIT Is a Potent Inhibitor of Pathological Choroidal Neovascularization in Mice
by: Songyi Seo, et al.
Published: (2021)

Targeted transscleral laser photocoagulation of the ciliary body in patients with neovascular glaucoma
by: Zadorozhnyy O., et al.
Published: (2019)

5α-Hydroxycostic acid inhibits choroidal neovascularization in rats through a dual signalling pathway mediated by VEGF and angiopoietin 2
by: Wulong Lei, et al.
Published: (2023)

Serum Amyloid A 4 as a Common Marker of Persistent Inflammation in Patients with Neovascular Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy
by: Liu Q, et al.
Published: (2023)

The influence of delayed treatment due to COVID-19 on patients with neovascular age-related macular degeneration and polypoidal choroidal vasculopathy
by: Xinyu Zhao, et al.
Published: (2021)

Single-Walled Carbon Nanotubes Mediated Neovascularity Targeted Antitumor Drug Delivery System
by: Chengqun Chen, et al.
Published: (2013)

Occult retinal neovascularization following intravitreal bevacizumab and laser treatment for retinopathy of prematurity
by: Wei Loon Ng, et al.
Published: (2024)

Fenofibrate suppresses corneal neovascularization by regulating lipid metabolism through PPARα signaling pathway
by: Tong Zhou, et al.
Published: (2022)

Transcriptome Profiling of Neovascularized Corneas Reveals miR-204 as a Multi-target Biotherapy Deliverable by rAAVs
by: Yi Lu, et al.
Published: (2018)